Glu-COACH: a Peer-mentoring Intervention to Reduce Disparities in Continuous Glucose Monitor (CGM) Use

Status: Recruiting
Location: See location...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

This is a study to develop and evaluate a peer mentoring intervention for Black and Latinx adolescents with type 1 diabetes to increase the initiation and maintenance of a continuous glucose monitoring (CGM) device. This device is a standard of care to improve diabetes management related to diet, exercise, and insulin. Use of CGM has been shown to improve health outcomes, but is not used by adolescents of color. Peer mentors may help improve usage.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 13
Maximum Age: 21
Healthy Volunteers: f
View:

• Diagnosis of type 1 diabetes, as determined clinically by the presence of ketosis or ketoacidosis at presentation and/or the presence of at least one diabetes-related auto-antibody

• Self-identification as Black and/or Latinx.

• Ability of participant to comprehend and communicate in written and spoken English, in order to complete surveys and participate in mentioning sessions and other interview (parents/caregivers do not need to have English fluency)

• Access to personal cellphone or tablet to participate in remote video sessions with the peer mentor

• using CGM \<50% of the time over the last 3 months

Locations
United States
Connecticut
Yale Children's Diabetes Clinic
RECRUITING
New Haven
Contact Information
Primary
Stuart A Weinzimer, MD
stuart.weinzimer@yale.edu
877.925.3637
Backup
Robin Whittemore, PhD, APRN, FAAN
robin.whittemore@yale.edu
203-737-2351
Time Frame
Start Date: 2024-05-21
Estimated Completion Date: 2027-02
Participants
Target number of participants: 38
Treatments
Experimental: Glu-COACH
The experimental group will receive ESOC plus peer-mentoring support from a peer of the same cultural identity (Glu-COACH) and access to a private social media group for all Black and Latinx teens to improve the initiation and maintenance of CGM (Dexcom)
Related Therapeutic Areas
Sponsors
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Leads: Yale University

This content was sourced from clinicaltrials.gov